Not applicableUnknownNCT01303276
What this trial is testing
Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)
Who this might be right for
Central Retinal Vein Occlusion
University of Toronto 30